Wall Street Is Warming Up to Aehr Test Systems (AEHR) Stock - Here’s Why
TLDR
- Oppenheimer initiated coverage on AEHR with an Outperform rating and a $120 price target
- The stock trades at $95.56, up 373% year-to-date
- Aehr’s Sonoma product is ramping with a leading hyperscaler via a record $41 million order
- The FOX-XP platform entered high-volume manufacturing with a major AI processor, including a $22 million follow-on order
- Oppenheimer projects fiscal 2027 and 2028 revenue of $141 million and $218 million respectively
Oppenheimer initiated coverage on Aehr Test Systems (AEHR) on Wednesday with an Outperform rating and a price target of $120, sending the stock into focus despite a 4.4% dip in premarket trading.
The stock currently trades at $95.56 and has climbed 373% year-to-date and 128% over the past six months.
Analyst Edward Yang said Aehr’s burn-in systems stress-test chips for early failures before deployment or costly packaging. The firm believes rising power and package value increases the cost of late failures, setting up Aehr for an AI-driven inflection.
… Continue reading the full article at the original source below.
This content is automatically aggregated. Full credit goes to the original publisher (coincentral.com).
